The Importance of Natriuretic Peptides in Cardiometabolic Diseases

por Vinnakota, Shravya, Chen, Horng H
Publicado 2020

Neprilysin in HFrEF: Differential Regulation of Tissue Versus Circulating Neprilysin

por Chen, Horng H., Burnett, John C.
Publicado 2020

Trimethylamine-N-Oxide: The Link Between Loop Diuretics and Cardiovascular Outcomes?

por Adel, Fadi W., Chen, Horng H.
Publicado 2021

The renal–cardiac connection in subjects with preserved ejection fraction: a population based study

por Jain, Amit, Scott, Christopher, Chen, Horng H.
Publicado 2017

Chronic natriuretic peptide protein therapeutics

por Chen, Horng H, Cataliotti, Alessandro, Burnett, John C
Publicado 2013

Treatment with CBA-NP a novel chimeric natriuretic peptide attenuates cardiorenal fibrosis and improves diastolic dysfunction in diabetic rat model

por Ameenuddin, Syed, Oehler, Elise A, Burnett, John C, Chen, Horng H
Publicado 2011

In-Vivo Evaluation of an In Situ Polymer Precipitation Delivery System for a Novel Natriuretic Peptide

por Lim, Soo Ghim, Venkatraman, Subbu S., Burnett, John C., Chen, Horng H.
Publicado 2013

The Vascular-Renal Connection in Patients Hospitalized With Hypertensive Crisis: A Population-Based Study

por Wan, Siu-Hin, Slusser, Joshua P., Hodge, David O., Chen, Horng H.
Publicado 2018

Incidence of Preclinical Heart Failure in a Community Population

por Young, Kathleen A., Scott, Christopher G., Rodeheffer, Richard J., Chen, Horng H.
Publicado 2022

Natriuretic peptide pathways in heart failure: further therapeutic possibilities

por Sangaralingham, S Jeson, Kuhn, Michaela, Cannone, Valentina, Chen, Horng H, Burnett, John C
Publicado 2022

A novel designer natriuretic peptide CD-NP suppresses TGF-beta 1 induced collagen Type I production in human cardiac fibroblasts

por Ichiki, Tomoko, Huntley, Brenda K, Sangaralingham, S Jeson, Chen, Horng H, Burnett, John C
Publicado 2009

Renal targeted protein therapeutics in experimental overt heart failure with renal dysfunction

por Chen, Horng H, Cataliotti, Alessandro, Martin, Fernando L, Schirger, John A, Burnett, John C
Publicado 2009

Mutation of three amino acids in the disulfide-ring of a CNP based chimeric natriuretic peptide alters its vascular properties

por Chen, Horng H, Huntley, Brenda K, Cataliotti, Alessandro, Martin, Fernando L, Burnett, John C
Publicado 2009

M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics

por McKie, Paul M, Cataliotti, Alessandro, Ichiki, Tomoko, Sangaralingham, S Jeson, Chen, Horng H, Burnett, John C
Publicado 2013

M‐Atrial Natriuretic Peptide and Nitroglycerin in a Canine Model of Experimental Acute Hypertensive Heart Failure: Differential Actions of 2 cGMP Activating Therapeutics

por McKie, Paul M., Cataliotti, Alessandro, Ichiki, Tomoko, Sangaralingham, S. Jeson, Chen, Horng H., Burnett, John C.
Publicado 2014

Cenderitide-Eluting Film for Potential Cardiac Patch Applications

por Ng, Xu Wen, Huang, Yingying, Chen, Horng H., Burnett, John C., Boey, Freddy Y. C., Venkatraman, Subbu S.
Publicado 2013

Insulin Therapy is Associated With Increased Myocardial Interstitial Fibrosis and Cardiomyocyte Apoptosis in a Rodent Model of Experimental Diabetes

por Adel, Fadi W., Zheng, Ye, Wan, Siu-Hin, Greason, Christie, Pan, Shuchong, Ameenuddin, Syed, Chen, Horng H.
Publicado 2022

The degree of natriuretic peptide system activation in stable and high risk CHF characterized by increased cystatin C is not reflected in cGMP activation

por Schirger, John A, Chen, Horng H, Slusser, Josh, Hodge, David, Heublein, Denise, Cataliotti, Alessandro, Sandberg, Sharon, Burnett, John C
Publicado 2009

Effects of phosphodiesterase V inhibition alone and in combination with BNP on cardiovascular and renal response to volume load in human preclinical diastolic dysfunction

por Wan, Siu‐Hin, McKie, Paul M., Slusser, Joshua P., Burnett, John C., Hodge, David O., Chen, Horng H.
Publicado 2021

Cenderitide, a novel dual GC-A and GC-B receptor activator, is a potent chronic cardiorenal fibroinhibiting peptide which suppresses aldosterone and reduces proteinuria in models o...

por Martin, Fernando L, McKie, Paul M, Sangaralingham, Jeson S, Ichiki, Tomoko, Harders, Gerald E, Chen, Horng H, Burnett, John C
Publicado 2011